Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Ocellaris Pharma, Inc.
Young Adult Survivors United
Sanofi
Cancer Trials Ireland
NuCana plc
National Institutes of Health Clinical Center (CC)
Numab Therapeutics AG
NantBioScience, Inc.
Aminex Therapeutics, Inc.
Pfizer
GlaxoSmithKline
Exelixis
Medikine, Inc.
Samsung Bioepis Co., Ltd.
CytomX Therapeutics
National Institutes of Health Clinical Center (CC)
NBE-Therapeutics AG
Hoffmann-La Roche
Oncorus, Inc.
West Virginia University
Duke University
Myriad Genetic Laboratories, Inc.
University of Arkansas
Queen's University, Belfast
National Institutes of Health Clinical Center (CC)
AbbVie
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
National Institutes of Health Clinical Center (CC)
Lumos Pharma
Pfizer
InSightec
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Avera McKennan Hospital & University Health Center
Novartis
Pfizer
CureOne
Pfizer
Tampere University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
AbbVie
AbbVie
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
Vanderbilt-Ingram Cancer Center
Celldex Therapeutics
AbbVie